| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |